Things noted from RNS30 Sep 2020 08:19
CDX bi-speci?c antibodies
· Extended development agreement with a leading global pharmaceutical company ("GlobalCo") to finalise manufacturability work and successfully bring CDX bi-specific antibody to a state of readiness for pre-clinical development
· Discussions regarding a potential licensing deal are continuing with GlobalCo following the extension of the Development Agreement
Question1???: Who are the other GlobalCo as this is defo not Eli Lilly!!
Concert Party Update
At the time of the Company's admission to the Standard Listing segment of the Official List in October 2017, various shareholders were deemed to be acting in concert, further details of which are provided in the Silver Falcon plc prospectus which can be viewed on the Company's website. It has now been agreed with the Takeover Panel that this original concert party can be broken up into two smaller concert parties and several individual shareholders, none of which are interested in shares carrying 30% or more of the voting rights of the Company.
Question 2?? Why is this still in here, is this 3 years old or is it new news!!